Table 5.
Comparison of major complications
| Study (year) | TACE | n (%) | TACE+MWA | n (%) | P |
|---|---|---|---|---|---|
| Zheng et al. (2018) | 4 liver abscess, 2 upper GI bleeding | 6 (3.6) | 1subcapsular hemorrhage, 1 liver abscess | 2 (2.2) | 0.791 |
| An et al. (2018) | NA | 1 (0) | 5 needle tract bleeding | 5 (14.2) | 0.024 |
| Zhang et al. (2017) | NA | 0 (0) | NA | 0 (0) | NA |
| Huo et al. (2017) | 1 death after liver abscess | 1 (3.1) | NA | 0 (0) | 0.471 |
| Dong et al. (2017) | NA | 0 (0) | NA | 0 (0) | NA |
| An et al. (2017) | 1subcapsular hemorrhage | 1 (2.0) | 2 subcapsular hemorrhage | 2 (4.1) | 1.000 |
| Zhou et al. (2016) | 4 jaundice | 4 (7.4) | 3 infection | 3 (5.6) | 1.000 |
| Yan et al. (2016) | 1 upper GI bleeding, 2 cholecystitis | 3 (9.3) | 1 needle track implantation | 1 (2.4) | 0.313 |
| Liu et al. (2016) | NA | 0 (0) | NA | 0 (0) | NA |
| He et al. (2016) | NA | 0 (0) | NA | 0 (0) | NA |
| Guo et al. (2015) | NA | 0 (0) | NA | 0 (0) | NA |
| Chang et al. (2015) | NA | 0 (0) | NA | 0 (0) | NA |
| Zhao et al. (2009) | NA | 0 (0) | NA | 0 (0) | NA |
| Liu et al. (2018) | 3 upper GI bleeding | 3 (5.7) | 1 upper GI bleeding, 2 local biliary obstruction | 3 (5.7) | 1.000 |
| Zhang et al. (2013) | NA | 0 (0) | NA | 0 (0) | NA |
| Shu et al. (2014) | 2 jaundice | 2 (8.3) | 1 local biliary obstruction | 1 (3.8) | 0.602 |
| Hu et al. (2013) | NA | 0 (0) | NA | 0 (0) | NA |
| Tao et al. (2016) | NA | 0 (0) | 1 local biliary obstruction | 1 (4.0) | 1.000 |
| Huang et al. (2015) | NA | 0 (0) | 2 subcapsular hemorrhage | 2 (8.0) | 0.489 |
| Xu et al. (2013) | NA | 0 (0) | NA | 0 (0) | NA |
TACE, transarterial chemoembolization; MWA, microwave ablation; NA, not available; GI, gastrointestinal.